Your session is about to expire
← Back to Search
Ralinepag for Lung Disease (CAPACITY Trial)
CAPACITY Trial Summary
This trial will test if ralinepag (a drug given to treat pulmonary arterial hypertension) can help improve patients' exercise capacity, as measured by how much oxygen they consume during exercise.
- Lung Disease
- High Blood Pressure
- Connective Tissue Disease
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension
- Vascular Disease
- Cardiovascular Disease
- Respiratory Diseases
CAPACITY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 45 Patients • NCT02279745CAPACITY Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
In how many different facilities is this trial being conducted today?
"There are a dozen medical centres presently enrolling patients for this clinical trial. If you enroll, you will be asked to travel to one of the locations, which include Tampa, Boston, Tucson, and 9 other cities. To cut down on travel, it is best to select a site that is close to your home."
Is this the first time this type of research has been conducted?
"Presently, 3 ongoing clinical trials for Ralinepag are being conducted in 109 cities and 33 nations. The inaugural study occurred in 2018 and was completed in Phase 3. The sponsor of this trial was United Therapeutics and it included 700 participants. Since 2018, a total of 18,241 similar studies have been conducted."
What other medical studies have included Ralinepag as a treatment option?
"Ralinepag is currently being studied in 3 clinical trials, with the majority of those trials being Phase 3. The central location for these studies is Leuven, SP, but there are a total of 425 locations running Ralinepag clinical trials."
What is the current status of Ralinepag's FDA approval process?
"There is both preclinical and clinical data supporting the safety of Ralinepag, so it received a score of 3."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger